Select Page

The Immunopharmacology Committee: Research & Publications

Research and Publications

Immuphar Publications:

 

    1. “Immunopharmacology and Inflammation” published by Springer, edited by Section members C. Riccardi, F. Levi-Schaffer, E. Tiligada, 2018.
    2. A new guide to immunopharmacology. Harding SD, Faccenda E, Southan C, Maffia P, Davies JA. Nat Rev Immunol. 2018 Dec;18(12):729.
    3. Scientists on the Spot: the Guide to Immunopharmacology as a new resource for the cardiovascular community. Maffia P, Mantovani A, Spedding M. Cardiovasc Res. 2019 Jan 1;115(1):e5-e6.
    4. Granulocyte-targeted therapies for airway diseases. Tavares LP, Peh HY, Tan WSD, Pahima H, Maffia P, Tiligada E, Levi-Schaffer F. Pharmacol Res. 2020 Jul;157:104881.
    5. Intravital multiphoton microscopy as a novel tool in the field of immunopharmacology. Morimoto A, Kikuta J, Ishii M. Pharmacol Ther. 2020 Feb;206:107429.
    6. The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology. Harding SD, Faccenda E, Southan C, Pawson AJ, Maffia P, Alexander SPH, Davenport AP, Fabbro D, Levi-Schaffer F, Spedding M, Davies JA. 2020 May;160(1):10-23.
    7. Guide to Immunopharmacology: a database to boost immunology education, research and therapy. Milling S, Spedding M, Maffia P. 2020 May;160(1):1-2.
    8. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. Alexander SPH, Armstrong JF, Davenport AP, Davies JA, Faccenda E, Harding SD, Levi-Schaffer F, Maguire JJ, Pawson AJ, Southan C, Spedding M. Br J Pharmacol. 2020 Nov;177(21):4942-4966.
    9. Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review: 31. Levi-Schaffer F, de Marco A. Br J Pharmacol. 2021 Sep;178(17):3359-3372.
    10. Spedding, M., Levi-Schaffer F. The impact of COVID-19 on research, vaccines and drugs: a key role for pharmacology. August 2021 issue of Pharmacology Today.
    11. Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review. Wainwright CL, Teixeira MM, Adelson DL, Buenz EJ, David B, Glaser KB, Harata-Lee Y, Howes MR, Izzo AA, Maffia P, Mayer AM, Mazars C, Newman DJ, Nic Lughadha E, Pimenta AM, Parra JA, Qu Z, Shen H, Spedding M, Wolfender JL. Pharmacol Res. 2022 Mar;177:106076.
    12. Comprehensive Pharmacology. vol. 5. (Tiligada, K., Ed. Immunopharmacology/Musculoskeletal System Pharmacology, Kenakin, T., Ed-in-Chief), Elsevier Inc., 304-320. ISBN: 978-0-12-820876-2.
    13. The legacy of penicillin’s first patient. Barrett MP. Pharmacol Res. 2023 Jun;192:106772.
    14. Immunopharmacology sessions at the 19th World Congress of Basic & Clinical Pharmacology 2023. Peh HY, Gurgone D, Maffia P. Pharmacol Res. 2023 Oct;196:106911.

Current Reports

November 2019 Activity Report

Edinburgh Immunoparmacology Meeting Report 2018

Past Reports

April 2015 Activity Report Immunopharmacology Section

March 2014 Activity Report Immunopharmacology Section

October 2013 Workshop on Immunopharmacology and Biotechnology in Cuba

March 2013 Activity Report Immunopharmacology Section

January 2013 Approval of Bylaws

November 2012 Section Proposal